It is apparent that if (or more accurately when) Brilacidin
It is apparent that if (or more accurately when) Brilacidin becomes the "go to" treatment for CV19 worldwide, how is IPIX going to ramp up enough manufacturing if it is going to take months just to get enough IV to run trials?
Even worse than delaying human trials would be to succeed at human trials and then still have many thousands of people dying because B-IV is not available. The RBL had to of made known the possibility B-IV may work on many other types of viruses, its already known anti-inflammation use that could be used in many uses needing urgent care for head, lungs, kidneys, and even possibly bowels to some degree so it is not like the inventory would go to waste if it doesn't play out for CV.
I believe the peer reviewed articles are being over hyped in regards to being necessary for govt grant approval. If the data they are receiving was coming from a corporate lab, then peer review is essential. But when the data is coming from your own labs, labs that you set up for being competent and the backbone of national defense in regards to bacterial/viral threats, then that should be good enough without needing others to tell you that your own labs were competent in running their investigations.
Govt can bring in millions of doses of other extremely iffy drugs yet one that looks strong, according to their own labs, has to scratch for manufacturing sites. Major disconnect from reality there IMO.
I am in favor of IPIX running a small private human trial in Europe or Asia ASAP to get additional data to aid in setting up the USA human trial. Would also let American medicine realize their pace of play isn't cutting it.
7
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...
Continue Reading
Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...
Continue Reading
The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...
Continue Reading
Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...
Continue Reading
Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...
Continue Reading
Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...
Continue Reading
Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...
Continue Reading
The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...
Continue Reading
Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...
Continue Reading
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
Top 5 Most Recently Viewed Articles
Introduction to the Crawford Nickel Project Canada Nickel Company Inc. has exciting news regarding its Crawford Nickel Project, which has been officially recognized by the Province of Ontario. This milestone comes as part of Ontario's One Project, One Process (1P1P) framework, a major step forward for the mining sector. Understanding the One Project, One Process Framework...
Continue Reading
TeamBridge Secures $28 Million to Revolutionize the Hourly Workforce TeamBridge, a rapidly expanding Workforce Operating System (Workforce OS), has successfully raised $28 million in Series B funding. This round was led by Mayfield, with considerable backing from existing investors, including General Catalyst and Abstract Ventures. This funding represents a significant...
Continue Reading
Pierre Fabre Laboratories and Iktos Unite for Oncology Drug Discovery Pierre Fabre Laboratories and Iktos have announced an exciting new collaboration aimed at transforming drug discovery in oncology. This partnership harnesses the strengths of both companies to utilize advanced AI technologies for developing new small-molecule drug candidates. Together, they plan to make...
Continue Reading
Vitamin Angels and Walgreens: A Transformative Partnership Vitamin Angels and Walgreens have reached a remarkable achievement, positively impacting the lives of 500 million women and children across the globe. Over the course of their partnership, they have dedicated themselves to providing essential vitamins and minerals primarily to underserved communities within the...
Continue Reading
Understanding the Flourishing Fluoropolymer Market in India India's fluoropolymer market is on an impressive trajectory, forecasted to reach a valuation of US$ 799.28 million by 2033 from US$ 425.12 million in 2024, reflecting an annual growth rate (CAGR) of 7.46% during the years ahead. This surge can be attributed to various factors, including technological...
Continue Reading